Global Sepsis Diagnostics Market is estimated to be US$ 1070 million by 2029 with a CAGR of 8.1% during the forecast period - by PMI
28 janv. 2021 10h35 HE
|
PMI
Covina CA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The global sepsis diagnostics market accounted for US$ 530.5 million in 2020 and is estimated to be US$ 1070 million by 2029 and is anticipated to...
T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results
13 févr. 2017 16h01 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Feb. 13, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic...
Study Published in the American Journal of Clinical Pathology Highlights Rapid Detection of Platelet Function Using T2MR® Technology
30 janv. 2017 06h30 HE
|
T2 Biosystems, Inc.
Study Shows T2MR’s Sensitive Detection of Platelet Function at Similar or Lower Platelet Counts than Traditional Tests Paper Provides Novel Insight Into Platelet Biology Not Evident Using...
T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress
09 janv. 2017 06h30 HE
|
T2 Biosystems, Inc.
-- On Track to Meet or Exceed Commercial Guidance and Regulatory Timelines -- LEXINGTON, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing...
T2 Biosystems, Inc. Announces $50M Credit Facility
05 janv. 2017 06h30 HE
|
T2 Biosystems, Inc.
-- Retiring Former Debt Facility; Significantly Decreases Near-Term Cash Needs -- LEXINGTON, Mass., Jan. 05, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing...
T2 Biosystems Announces New Data at IDWeek 2016
03 nov. 2016 16h01 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that the...
T2 Biosystems Announces Presentations at IDWeek 2016
13 oct. 2016 08h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the Company’s...
T2 Biosystems Announces $40 Million Equity Investment by Partner Canon U.S.A.
22 sept. 2016 08h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the purchase...
T2 Biosystems Presents Data on the Company’s T2MR® Technology for the Detection of the Bacteria that Causes Lyme Disease Directly from Whole Blood at Cold Spring Harbor Laboratory Conference on Diagnostic Tests for Lyme Disease
21 sept. 2016 16h01 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, announced that Tom Lowery,...
T2 Biosystems Reports 2016 Second Quarter, Six-Month Results
01 août 2016 16h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today reported operating...